DE HB364 | 2023-2024 | 152nd General Assembly
Status
Completed Legislative Action
Spectrum: Strong Partisan Bill (Democrat 12-1)
Status: Passed on August 2 2024 - 100% progression
Action: 2024-08-02 - Signed by Governor
Text: Latest bill text (Draft #1) [HTML]
Spectrum: Strong Partisan Bill (Democrat 12-1)
Status: Passed on August 2 2024 - 100% progression
Action: 2024-08-02 - Signed by Governor
Text: Latest bill text (Draft #1) [HTML]
Summary
This Act requires that individual, blanket, and group health insurance carriers cover drug treatment for the associated conditions of metastatic cancer in the same way treatment for metastatic cancer is covered. Specifically, it requires insurance companies to cover any FDA approved drug prescribed to treat the side effects of metastatic cancer treatment and prohibits insurance companies from mandating that patients first fail to respond to a different drug or prove a history of failure of such drug. Technical changes are also made to comply with the Delaware Legislative Drafting Manual.
Titel
An Act To Amend Title 18 Of The Delaware Code Relating To Cancer Coverage.
Sponsors
Roll Calls
2024-06-25 - Senate - Senate Third Reading (Y: 21 N: 0 NV: 0 Abs: 0) [PASS]
2024-06-11 - House - House Third Reading (Y: 39 N: 0 NV: 0 Abs: 2) [PASS]
2024-06-11 - House - House Third Reading (Y: 39 N: 0 NV: 0 Abs: 2) [PASS]
History
Date | Chamber | Action |
---|---|---|
2024-08-02 | Signed by Governor | |
2024-06-25 | Passed By Senate. Votes: 21 YES | |
2024-06-18 | Reported Out of Committee (Banking, Business, Insurance & Technology) in Senate with 1 Favorable, 5 On Its Merits | |
2024-06-11 | Assigned to Banking, Business, Insurance & Technology Committee in Senate | |
2024-06-11 | Passed By House. Votes: 39 YES 2 ABSENT | |
2024-04-16 | Reported Out of Committee (Economic Development/Banking/Insurance & Commerce) in House with 5 Favorable, 4 On Its Merits | |
2024-04-11 | Introduced and Assigned to Economic Development/Banking/Insurance & Commerce Committee in House |